NK-1 receptor antagonists inhibit the proliferation (inducing the apoptosis of PC cells) and the migratory activity of tumor cells; they exert an anti-angiogenic effect, and they counteract the Warburg effect. This evidence concerns the gene TACR1 and neoplasm.